STEM Healthcare appoints Dermot Kenny as new CEO
14 December 2021
Leading global pharmaceutical and life sciences auditing firm, STEM Healthcare, part of Ashfield Advisory, has appointed Dermot Kenny as its new CEO.
Dermot has extensive experience in the pharmaceutical industry spanning over 25 years. His most recent role was leading Novartis’ Global Clinical Technology and Innovation team.
Throughout his career, he has successfully led large global teams, built large-scale custom client solutions, implemented various clinical development platforms and driven organizational transformation.
At STEM Healthcare, Dermot will be responsible for driving growth, diversifying the company’s offering and expanding its geographic reach and global presence.
STEM Healthcare partners with clients to evaluate and improve field team performance, using a one-of-a-kind benchmark database that includes more than 500,000 in-field observations completed across 59 countries.
Speaking about his appointment, Dermot commented: “It’s a privilege to join STEM Healthcare at such a pivotal time for the industry and in the company’s journey. STEM Healthcare has an exceptional reputation and works with many of the leading companies in the Pharma and Biotech sectors to help enhance their performance at a time when the market is becoming increasingly complex and competitive.
“Our success has been built on the quality of STEM Healthcare’s people, their credibility and ability to engage productively with both local and global functions. I’m very excited to be leading the next phase of STEM Healthcare’s growth.”
STEM Healthcare quantifies and benchmarks strategic alignment from leadership direction to field execution, working with clients to pinpoint strengths and create opportunities to improve performance across Commercial, Medical, Access and First-Line Manager teams.
Part of Ashfield Advisory, a business unit of Ashfield, STEM Healthcare works alongside Vynamic, Putnam Associates and SmartAnalyst, combining their expertise to provide integrated services to customers.
For more information please visit: www.stemhealthcare.com
For media enquiries, please contact Lara Lovenbury +44 797 247 1903 email@example.com
About STEM Healthcare
STEM, an Ashfield Advisory company, is a global pharmaceutical and life sciences auditing firm partnering with clients to further accelerate field team performance. STEM’s powerful, one-of-a-kind benchmark database includes more than 500,000 in-field observations completed across 59 countries. Projects are designed to quantity and benchmark strategic alignment from leadership direction to field execution. STEM works with clients, acting as the eyes and ears of a business, to pinpoint strengths to build from and opportunities to improve for Commercial, Medical, Access and First-Line Manager teams.
For further information visit our website at www.stemhealthcare.com
About Ashfield Advisory
Ashfield Advisory, part of UDG Healthcare plc, is an ecosystem of connected advisory and consulting businesses including Vynamic, Putnam Associates, PHMR, STEM and SmartAnalyst. All four businesses have specific areas of expertise and are focused on market access and shaping the healthcare industry by hiring top talent, building deep industry expertise, cultivating a boutique approach to client partnerships, and capitalising on the team’s expansive research and data insights.
Under the Ashfield umbrella, part of UDG Healthcare, Ashfield Advisory sits alongside Ashfield Engage and Ashfield Health.
For more information, go to www.ashfieldadvisory.com